We are live on ! Find out more
MCM

Marathon Capital Management Portfolio holdings

AUM $445M
1-Year Est. Return 26.09%
This Fund
S&P 500
This Quarter Est. Return
+10.44%
1 Year Est. Return
+26.09%
3 Year Est. Return
+49.93%
5 Year Est. Return
+48.4%
10 Year Est. Return
+349.58%
AUM
$245M
AUM Growth
+$21.3M
Cap. Flow
+$3.16M
Cap. Flow %
1.29%
Top 10 Hldgs %
67.31%
Holding
121
New
11
Increased
28
Reduced
53
Closed
9

Top Buys

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$2.24M
2
CVS icon
CVS Health
CVS
+$2.2M
3
NOK icon
Nokia
NOK
+$2M
4
ROKU icon
Roku
ROKU
+$1.16M
5
TPIC
TPI Composites
TPIC
+$980K

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$2.65M
2
CRCM
CARE.COM, INC.
CRCM
+$2.02M
3
ORBC
ORBCOMM, Inc.
ORBC
+$765K
4
ENPH icon
Enphase Energy
ENPH
+$516K
5
ENZ
Enzo Biochem, Inc.
ENZ
+$404K

Sector Composition

Rank Sector Weight
1 Financials 56.13%
2 Technology 17.14%
3 Healthcare 6.89%
4 Energy 5.17%
5 Industrials 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TROW icon
1
T. Rowe Price
TROW
$25.1B
$131M 53.4%
1,193,591
-3,080
-0.3% -$324K
ENPH icon
2
Enphase Energy
ENPH
$5.48B
$7.53M 3.07%
412,986
-37,489
-8% -$516K
AAPL icon
3
Apple
AAPL
$4.9T
$4.16M 1.7%
84,092
-1,700
-2% -$82.8K
CY
4
DELISTED
Cypress Semiconductor
CY
$3.61M 1.47%
162,467
-6,713
-4% -$122K
QCOM icon
5
Qualcomm
QCOM
$181B
$3.61M 1.47%
47,454
-747
-2% -$54.7K
MSFT icon
6
Microsoft
MSFT
$2.93T
$3.58M 1.46%
26,699
-1,443
-5% -$183K
JNJ icon
7
Johnson & Johnson
JNJ
$609B
$3.16M 1.29%
22,703
+242
+1% +$33.5K
GLW icon
8
Corning
GLW
$133B
$2.9M 1.18%
87,150
-567
-0.6% -$18.2K
GSK icon
9
GSK
GSK
$104B
$2.84M 1.16%
56,714
-524
-0.9% -$26.3K
AL
10
DELISTED
Air Lease Corp
AL
$2.72M 1.11%
65,750
-640
-1% -$24.4K
CEF icon
11
Sprott Physical Gold and Silver Trust
CEF
$7.3B
$2.5M 1.02%
189,198
-2,400
-1% -$30K
TRGP icon
12
Targa Resources
TRGP
$60.7B
$2.43M 0.99%
61,965
+15,280
+33% +$607K
ABB
13
DELISTED
ABB Ltd
ABB
$2.38M 0.97%
118,682
+6,550
+6% +$128K
KRNT icon
14
Kornit Digital
KRNT
$696M
$2.36M 0.96%
74,625
-900
-1% -$24.8K
BP icon
15
BP
BP
$108B
$2.33M 0.95%
56,796
-523
-0.9% -$21.9K
MET icon
16
MetLife
MET
$60.5B
$2.31M 0.94%
46,455
-550
-1% -$25.9K
CVS icon
17
CVS Health
CVS
$137B
$2.22M 0.91%
+40,818
New +$2.2M
KN icon
18
Knowles
KN
$3.01B
$2.22M 0.91%
121,448
+4,849
+4% +$85.5K
MYGN icon
19
Myriad Genetics
MYGN
$584M
$2.21M 0.9%
+79,460
New +$2.24M
MIC
20
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$2.18M 0.89%
53,735
-2,749
-5% -$113K
NOK icon
21
Nokia
NOK
$56.5B
$2.08M 0.85%
415,150
+380,150
+1,086% +$2M
DSKE
22
DELISTED
Daseke, Inc. Common Stock
DSKE
$2.03M 0.83%
564,150
-5,100
-0.9% -$24.2K
MDC
23
DELISTED
M.D.C. Holdings, Inc.
MDC
$2.02M 0.82%
66,437
+149
+0.2% +$4.39K
IBM icon
24
IBM
IBM
$200B
$1.93M 0.79%
14,630
+124
+0.9% +$16.3K
CVA
25
DELISTED
Covanta Holding Corporation
CVA
$1.68M 0.69%
93,805
-4,500
-5% -$79.4K
1
2 3 4 5

Similar funds

RWM
Rialto Wealth Management Syracuse, New York $445M AUM 15.58% 1-Year Est. Return
WC
Weil Company San Diego, California $445M AUM 14.95% 1-Year Est. Return
NAMP
NorthStar Asset Management (Pennsylvania) Blue Bell, Pennsylvania $445M AUM 17.9% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return
MLIC
Mandatum Life Insurance Company Helsinki, Finland $445M AUM 26.43% 1-Year Est. Return
JDLA
J. Derek Lewis & Associates Newport Beach, California $445M AUM
GC
Guidance Capital Lousville, Kentucky $446M AUM 19.83% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $446M AUM 13.55% 1-Year Est. Return

Marathon Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Marathon Capital Management held 121 positions worth $245M, up 9.5% from $224M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Marathon Capital Management's Q2 2019 filing shows 11 new, 28 increased, 53 reduced and 9 closed positions. Its largest new stake was Myriad Genetics: 79,460 shares worth $2.21M. The largest sale was DuPont de Nemours, an estimated $2.65M.

By sector, the portfolio is most concentrated in Financials at 56% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.

  • Marathon Capital Management's largest Q2 2019 buy was Myriad Genetics: 79,460 shares worth $2.21M.
  • Marathon Capital Management added most to Nokia in Q2 2019, an estimated $2M increase.
  • Marathon Capital Management's biggest Q2 2019 reduction was ORBCOMM, Inc., cutting an estimated $765K.
  • Marathon Capital Management fully exited DuPont de Nemours in Q2 2019, selling an estimated $2.65M.
  • Marathon Capital Management's ten largest holdings make up 67% of its $245M portfolio in Q2 2019.
  • Marathon Capital Management opened 11 new positions and closed 9 in Q2 2019.
  • Marathon Capital Management's portfolio value rose 9.5% quarter-over-quarter to $245M.

Based on Marathon Capital Management's 13F filing for Q2 2019, filed 25 Jul 2019.